Genomic Analysis of Circulating Tumor DNA Identifies Recurrent Molecular Features with Clinical Significance in Advanced Prostate Cancer

Autor: Yang, D.D., Francini, E., Crowdis, J., Riaz, I. Bin, Rickles-Young, M., Tsuji, J., Cibulskis, C., Flaherty, M., Whelpley, B., Reardon, B., Park, J., Huang, F.W., Van Allen, E.M., Choudhury, A.D.

Publikováno v: In International Journal of Radiation Oncology, Biology, Physics 1 November 2022 114(3) Supplement:e250-e250

Combined Fixed-duration Systemic Treatment and Metastasis-directed Radiotherapy for Oligometastatic Hormone-sensitive Prostate Cancer.

Autor: Ravi P; Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address: praful_ravi@dfci.harvard.edu., Zhong C; Dana-Farber Cancer Institute, Boston, MA, USA., Xie W; Dana-Farber Cancer Institute, Boston, MA, USA., Kelly E; Dana-Farber Cancer Institute, Boston, MA, USA., Whelpley B; Dana-Farber Cancer Institute, Boston, MA, USA., Kuczmarski K; Dana-Farber Cancer Institute, Boston, MA, USA., Beltran H; Dana-Farber Cancer Institute, Boston, MA, USA., Kilbridge KL; Dana-Farber Cancer Institute, Boston, MA, USA., King MT; Dana-Farber Cancer Institute, Boston, MA, USA; Brigham & Women's Hospital, Boston, MA, USA., McGregor BA; Dana-Farber Cancer Institute, Boston, MA, USA., Morgans AK; Dana-Farber Cancer Institute, Boston, MA, USA., Pomerantz M; Dana-Farber Cancer Institute, Boston, MA, USA., Taplin ME; Dana-Farber Cancer Institute, Boston, MA, USA., Tewari AK; Dana-Farber Cancer Institute, Boston, MA, USA., Viswanathan SR; Dana-Farber Cancer Institute, Boston, MA, USA., Wei XX; Dana-Farber Cancer Institute, Boston, MA, USA., Anh Huynh M; Dana-Farber Cancer Institute, Boston, MA, USA; Brigham & Women's Hospital, Boston, MA, USA., Choudhury AD; Dana-Farber Cancer Institute, Boston, MA, USA.

Publikováno v: European urology oncology [Eur Urol Oncol] 2024 Nov 14. Date of Electronic Publication: 2024 Nov 14.